U.S. Offers Pakistan Help In Creating Drug Regulatory Agency
This article was originally published in PharmAsia News
The United States has offered Pakistan's new government help in establishing a drug regulation system. Although Pakistan has no production plants that have the approval of the U.S. FDA, it exports about $484 million worth of medicines a year. U.S. Health and Human Services Secretary Michael Leavitt made the offer in meetings with Prime Minister Yousuf Raza Gilani and Health Minister Sherry Rehman. The assistance would include offering expertise in establishing best practices and setting up an FDA type of regulatory authority. (Click here for more
You may also be interested in...
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.
The two companies can now market their HER-2 targeting antibody-drug conjugate in its second tumor type as they look to expand beyond breast cancer.
Coronavirus Notebook: EMA Data Hack Aimed At 'Undermining Trust' In Vaccines, Russia Plans EU Sputnik V Filing Next Month
France has reported on side-effect reports concerning the Pfizer/BioNTech vaccine, and the World Health Organization has warned that plans to provide global equitable access to coronavirus vaccines are at risk.